Keymed launches $400m Hong Kong IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Asia

Keymed launches $400m Hong Kong IPO

Pharma_drugs_adobe_575x375.jpg

Chinese biotechnology company Keymed Biosciences has hit the market with an up to HK$3.1bn ($400.1m) IPO.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article